首页> 美国卫生研究院文献>Molecular Therapy >Bioengineering Thymus Organoids to Restore Thymic Function and Induce Donor-Specific Immune Tolerance to Allografts
【2h】

Bioengineering Thymus Organoids to Restore Thymic Function and Induce Donor-Specific Immune Tolerance to Allografts

机译:生物工程胸腺器官可恢复胸腺功能并诱导供体对同种异体移植的免疫耐受

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

One of the major obstacles in organ transplantation is to establish immune tolerance of allografts. Although immunosuppressive drugs can prevent graft rejection to a certain degree, their efficacies are limited, transient, and associated with severe side effects. Induction of thymic central tolerance to allografts remains challenging, largely because of the difficulty of maintaining donor thymic epithelial cells in vitro to allow successful bioengineering. Here, the authors show that three-dimensional scaffolds generated from decellularized mouse thymus can support thymic epithelial cell survival in culture and maintain their unique molecular properties. When transplanted into athymic nude mice, the bioengineered thymus organoids effectively promoted homing of lymphocyte progenitors and supported thymopoiesis. Nude mice transplanted with thymus organoids promptly rejected skin allografts and were able to mount antigen-specific humoral responses against ovalbumin on immunization. Notably, tolerance to skin allografts was achieved by transplanting thymus organoids constructed with either thymic epithelial cells coexpressing both syngeneic and allogenic major histocompatibility complexes, or mixtures of donor and recipient thymic epithelial cells. Our results demonstrate the technical feasibility of restoring thymic function with bioengineered thymus organoids and highlight the clinical implications of this thymus reconstruction technique in organ transplantation and regenerative medicine.
机译:器官移植的主要障碍之一是建立同种异体移植物的免疫耐受性。尽管免疫抑制药物可以在一定程度上阻止移植物排斥,但其作用有限,短暂,并伴有严重的副作用。诱导胸腺对同种异体移植物的中枢耐受性仍然具有挑战性,主要是因为难以在体外维持供体胸腺上皮细胞以成功进行生物工程。在这里,作者表明从脱细胞的小鼠胸腺产生的三维支架可以支持胸腺上皮细胞在培养中的存活并保持其独特的分子特性。当将生物工程化的胸腺类器官移植到无胸腺裸鼠中时,可有效促进淋巴细胞祖细胞的归巢并支持胸腺造血。移植有胸腺器官的裸鼠可迅速排斥同种异体皮肤,并能在免疫后对卵清蛋白产生抗原特异性的体液反应。值得注意的是,对皮肤同种异体移植的耐受性是通过移植与共表达同基因和同种异体主要组织相容性复合物的胸腺上皮细胞或供体和受体胸腺上皮细胞的混合物一起构建的胸腺类器官来实现的。我们的结果证明了用生物工程化的胸腺类器官恢复胸腺功能的技术可行性,并强调了这种胸腺重建技术在器官移植和再生医学中的临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号